Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
588060.SH
ETF Financing Ranking | GF Fund SSE Science and Technology Innovation Board 50 ETF (588060) had a net financing buy-in of CNY 16.3 million
Tags:
GF Fund SSE Science and Technology Innovation Board 50 ETF
588060.SH
NewTimeSpace
2026-09-07
ETF Financing Ranking | GF Fund SSE Science and Technology Innovation Board 50 ETF (588060) had a net financing buy-in of CNY 29.64 million on Aug 3, ranked in the top 3 among comparable funds
Tags:
GF Fund SSE Science and Technology Innovation Board 50 ETF
588060.SH
NewTimeSpace
2026-08-04
ETF Financing Ranking | GF Fund SSE Science and Technology Innovation Board 50 ETF (588060) had a net financing buy-in of CNY 24.65 million, ranked in the top 3 among comparable funds
Tags:
GF Fund SSE Science and Technology Innovation Board 50 ETF
588060.SH
NewTimeSpace
2026-07-20
GF China Science And Technology Innovation Board 50 Component ETF(588060) surges 4.65% intraday, two-year return hits 136.64%
Tags:
ETF
GF China Science And Technology Innovation Board 50 Component ETF
588060.SH
2026-05-25
Hwabao WP CSI Electronic 50 ETF (588060) Rises 3.16%, Ranks First Among Comparable Funds in New AUM Growth Over the Past Year
Tags:
ETF
Hwabao WP CSI Electronic 50 ETF
588060.SH
2026-04-30
GF China Science And Technology Innovation Board 50 Component ETF (588060) Rises 3.16%, Sees AUM Growth of 1.620 Billion Yuan Over the Past Year
Tags:
ETF
588060.SH
GF China Science And Technology Innovation Board 50 Component ETF
2026-04-30
Finance
GOLDWIND (02208.HK): issues RMB 500 mln green bond at 1.98%
Finance
INGENIC (03223.HK): registration change done, capital RMB 515 mln
Finance
FS.COM (03355.HK): trustee buys 47,600 H shares under award scheme
Finance
GUOCO GROUP (00053.HK): unit signs JV for Berlayar Drive site
Finance
EMPEROR E HOTEL (00296.HK): sees interim turnaround to profit
Finance
FOSUN PHARMA (02196.HK): HLX109 cleared for Phase I trial in Australia
Finance
TONGRENTANGCARE (02667.HK): senior manager buys 100,000 shares
Finance
FOSUN PHARMA (02196.HK): FXS6837 starts Phase III trial in China
Finance
HENGRUI PHARMA (01276.HK): two drugs get clinical trial approval
Finance
CITIC FAMC (02799.HK): Dong Hong's employee director role approved
Scan QR Code
Download App